7th International Inflammatory Breast Cancer Symposium: Understanding and Managing Aggressive Breast Cancer

---

LIVEIBCBreast CancerBreast Inflammation

Sunday, December 4, 2022, 9:00 AM - Monday, December 5, 2022, 5:30 PM, Houston Marriott Medical Center


AMA PRA Category 1 Credits™ (12.25 hours), ANCC - Nursing Contact Hour(s) (12.00 hours), General Attendance (12.00 hours), Non-Physician Attendance (12.25 hours)

Inflammatory breast cancer (IBC) is a highly aggressive breast cancer with a very poor prognosis relative to other breast cancers due to its strong potential to metastasize, relapse, and possibly result in patient death. There have been multiple attempts to develop efficacious targeted therapy for this disease. Unfortunately, the federal government (FDA) has not approved any IBC-specific drugs or diagnostic tools yet. Therefore, there remains an urgent need to understand mechanistically how to induce a therapeutic effect that can prolong the survival of patients with IBC. This two-day meeting is targeted for clinical investigators, physicians, basic researchers, nurses, patient advocates and institutions aiming to pioneer IBC clinics in their geographic regions, to enhance their knowledge and to facilitate collaboration to accelerate clinical therapy and research trial development beneficial for patients with IBC. We expect new ideas and collaborations from this meeting to lead to improvement of disease outcome, such as survival or tumor response, over the next 3 years.

1. Review and acknowledge IBC and non-IBC standard of care diagnosis and treatment
2. Discuss ongoing clinical trials of IBC and novel new treatments in breast cancer from both the biology perspective and operations to discuss expansion of collaboration in the US
3. Learn new concepts in the biology and latest developments of the ongoing translational research related to IBC and non-IBC aggressive breast cancer and utilize them in practice
4. Discuss how we can translate our basic research findings as clinical research or into the clinic

1. At the conclusion of this activity, the registered nurse will be able to incorporate the updated standards of practice in the use of immunotherapy and new targeted therapies in the treatment of IBC by self reporting at least 2 new concepts.

On-site registration for the 7th International Inflammatory Breast Cancer Symposium: Understanding and Managing Aggressive Breast Cancer, will open at 9:00 am on Sunday, December 4, 2022, and the symposium will begin at 9:30 am.  The symposium will adjourn at 5:30 pm on Monday, December 5, 2022. Advanced registration is encouraged as space and materials are limited.  Please see registration information for applicable fees.

The deadline for advanced registration is November 9, 2022.

Registration Fees:

Registration Category	Before Nov. 9	After Nov. 9
In-Person Attendance
Physicians/Scientist (MD, PhD)	$100.00	$125.00
Healthcare Professionals	$80.00	$95.00
Trainees	$40.00	$40.00
Patients, Caregivers, and  Advocates	$20.00	$20.00
Virtual Attendance (Physicians/Scientists, Healthcare Professionals)	$300.00	$350.00
Virtual Attendance (Patients, Advocates, Caregivers)	$50.00	$50.00

            

We accept the following forms of payment:

•Credit Cards (MasterCard, VISA, and American Express)
•Check (Payable to The University of Texas MD Anderson Cancer Center; through U.S. banks only)

Mail checks to:
   Continuing Professional Education (CPE) – Unit 1781
   The University of Texas MD Anderson Cancer Center
   P.O. Box 301407
   Houston, Texas 77230-1407

When registering online a receipt (confirmation email) will be automatically emailed to the e-mail address you list on the registration form.

Telephone registrations are not accepted.

Refund/Cancellation Policy
The registration fee, minus a $15 administration-handling fee, is refundable if a written request is received on or before November 9, 2022. No refunds will be granted after this date. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.

The Department of Continuing Professional Education (CPE), reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or at the phone number given on the registration form.  In case of activity cancellation, the liability of the CPE is limited to the registration fee. CPE will refund the full registration fee.

CPE reserves the right to limit the number of participants in an activity and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

For additional information or for Special Assistance, contact CPE at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected]

Evaluation
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.  The survey link will be provided during the review course.

Accreditation/Credit Designation – Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Texas MD Anderson Cancer Center and Inflammatory Breast Cancer International Consortium | IBC-IC. The The University of Texas MD Anderson Cancer Center is accredited by the ACCME to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing
The University of Texas MD Anderson Cancer Center is accredited with distinction as a provider of Nursing Continuing Professional Development by The American Nurses Credentialing Center’s Commission on Accreditation.

The University of Texas MD Anderson Cancer Center designates this live activity will award 12.00 Nursing Continuing Professional Development (NCPD) contact hours.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

Accommodations

• A block of rooms has been reserved for conference attendees at the Houston Marriott Medical Center Hotel, 6580 Fannin Street, Houston, Texas 77030
• Early hotel reservation is suggested; the group rate is offered through November 11, 2022. The hotel phone number is 713-796-0080.
• When you make reservations, be sure to mention the MD Anderson IBC Conference to be assured of receiving the special meeting rate of $159.USD per night. Reservations and deposits received after November 11, 2022 will be confirmed if space is available and at currently published hotel guest room rates.

• You can also use the registration link to receive the group rate:
  Book your group rate for MD Anderson IBC Conference

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

You are invited to support / exhibit at the 7th International Inflammatory Breast Cancer Symposium: Understanding/Managing Aggressive Breast Cancer that will be held on December 4-5, 2022.

Gold: $15,000

Five complimentary full conference registrations (additional attendees are $350 per person)
Place promotional materials on a designated literature table
Recognition at the Gold level
Recognition as a Catering Supporter
Recognition as a Welcome Reception Supporter
Company name on prominent conference signage and power point rotation
Premium exhibit spot
One Exhibit tables –draped 6’ x 30” display table and two chairs
Interaction with faculty and attendees during meals and breaks

Silver: $10,000

Four complimentary full conference registrations (additional attendees are $350 per person)
Recognition at the Silver level
Recognition as a Welcome Reception Supporter
Company name on prominent conference signage and power point rotation
Premium exhibit spot
One Exhibit tables –draped 6’ x 30” display table and two chairs
Interaction with faculty and attendees during meals and breaks

Bronze: $7,500

Three complimentary full conference registrations (additional attendees are $350 per person)
Recognition at the Bronze level
Recognition as a Welcome Reception Supporter
Company name on prominent conference signage and power point rotation
One Exhibit table – draped 6’ x 30” display table and two chairs
Interaction with faculty and attendees during meals and breaks

Exhibitor: $5,000

Two complimentary full conference registrations (additional attendees are $350 per person)
Recognition at the Exhibitor level
Company name on prominent conference signage and power point rotation
One Exhibit table – draped 6’ x 30” display table and two chairs
Interaction with faculty and attendees during meals and breaks

W9 Form Exhibit at this Event